|
ZFAND1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.202100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.244690E-04 |
| Normal-vs-Stage2 |
8.313900E-02 |
| Normal-vs-Stage3 |
9.268600E-01 |
| Normal-vs-Stage4 |
1.547830E-02 |
| Stage1-vs-Stage2 |
9.169600E-01 |
| Stage1-vs-Stage3 |
4.137000E-03 |
| Stage1-vs-Stage4 |
1.8484999997348E-07 |
| Stage2-vs-Stage3 |
8.140400E-02 |
| Stage2-vs-Stage4 |
3.976300E-03 |
| Stage3-vs-Stage4 |
6.658200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.540200E-02 |
| Normal-vs-AfricanAmerican |
3.521800E-01 |
| Normal-vs-Asian |
6.007400E-01 |
| Caucasian-vs-AfricanAmerican |
1.557760E-02 |
| Caucasian-vs-Asian |
9.541000E-01 |
| AfricanAmerican-vs-Asian |
3.082800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.016640E-01 |
| Normal-vs-Female |
4.655900E-02 |
| Male-vs-Female |
4.517800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.005800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.617000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.719900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.316600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.037200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.182600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.064400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.810200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.253200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.289400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.339900E-02 |
| Normal-vs-Grade 2 |
7.06889999979587E-07 |
| Normal-vs-Grade 3 |
9.439800E-01 |
| Normal-vs-Grade 4 |
3.014100E-04 |
| Grade 1-vs-Grade 2 |
8.766800E-01 |
| Grade 1-vs-Grade 3 |
8.768200E-02 |
| Grade 1-vs-Grade 4 |
7.028100E-04 |
| Grade 2-vs-Grade 3 |
3.66139999996573E-06 |
| Grade 2-vs-Grade 4 |
2.55460097520199E-11 |
| Grade 3-vs-Grade 4 |
5.631900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.4039004120624E-10 |
| Normal-vs-ccB subtype |
8.698200E-02 |
| ccA subtype-vs-ccB subtype |
3.11428660637603E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.735700E-02 |
| Normal-vs-N1 |
1.609770E-04 |
| N0-vs-N1 |
3.184500E-04 |
|
|
